tiprankstipranks
Advertisement
Advertisement
Michael Okunewitch Initiates Buy on Evaxion, Citing Strong Clinical Data, AI-Driven Vaccine Platform, and Cash Runway to 2H 2027
PremiumRatingsMichael Okunewitch Initiates Buy on Evaxion, Citing Strong Clinical Data, AI-Driven Vaccine Platform, and Cash Runway to 2H 2027
2M ago
Evaxion Posts Q1 2026 Results as AI-Immunology Platform Hits Key Cancer Vaccine Milestone
Premium
Company Announcements
Evaxion Posts Q1 2026 Results as AI-Immunology Platform Hits Key Cancer Vaccine Milestone
2M ago
Evaxion Biotech Schedules Q1 2026 Results and Business Update for May 7
Premium
Company Announcements
Evaxion Biotech Schedules Q1 2026 Results and Business Update for May 7
2M ago
Evaxion Unveils New Glioblastoma Vaccine Data Showcasing Scalability of AI-Immunology Platform
PremiumCompany AnnouncementsEvaxion Unveils New Glioblastoma Vaccine Data Showcasing Scalability of AI-Immunology Platform
3M ago
Evaxion Posts Strong Phase 2 Data as AI-Designed Cancer Vaccine Hits 86% Target Precision
Premium
Company Announcements
Evaxion Posts Strong Phase 2 Data as AI-Designed Cancer Vaccine Hits 86% Target Precision
3M ago
Evaxion says EVX-01 demonstrates 86% vaccine target precision in trial
Premium
The Fly
Evaxion says EVX-01 demonstrates 86% vaccine target precision in trial
3M ago
Evaxion to Unveil AI-Designed Polio and CMV Vaccine Concepts at World Vaccine Congress
PremiumCompany AnnouncementsEvaxion to Unveil AI-Designed Polio and CMV Vaccine Concepts at World Vaccine Congress
3M ago
Evaxion Calls April 16, 2026 AGM to Expand Capital and Warrant Authorizations
Premium
Company Announcements
Evaxion Calls April 16, 2026 AGM to Expand Capital and Warrant Authorizations
4M ago
Evaxion Biotech Sets April 16, 2026 Date for Annual General Meeting
Premium
Company Announcements
Evaxion Biotech Sets April 16, 2026 Date for Annual General Meeting
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100